• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Logan Thomas D covered exercise/tax liability with 54,143 shares, decreasing direct ownership by 1% to 3,943,501 units (SEC Form 4)

    4/3/25 4:24:25 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials
    Get the next $MIR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Logan Thomas D

    (Last) (First) (Middle)
    1218 MENLO DRIVE

    (Street)
    ATLANTA GA 30318

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Mirion Technologies, Inc. [ MIR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    04/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 04/01/2025 F 54,143(1) D $14.5 3,943,501 D
    Class B Common Stock 1,544,017 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares that have been withheld by the Issuer in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units (RSUs) previously granted to the Reporting Person. Such withholding was mandated by the Issuer by a policy adopted in advance and does not represent a discretionary trade by the Reporting Person.
    Remarks:
    /s/ Emmanuelle Lee, attorney-in-fact for Thomas D. Logan 04/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MIR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MIR

    DatePrice TargetRatingAnalyst
    12/19/2024$22.00Outperform
    Robert W. Baird
    9/26/2024$14.00Buy
    B. Riley Securities
    5/26/2023$11.00Buy
    Citigroup
    3/24/2022$13.00Market Outperform
    CJS Securities
    11/29/2021$14.00Buy
    Goldman Sachs
    10/25/2021$14.00Buy
    Citigroup
    More analyst ratings

    $MIR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Mirion Technologies Inc.

      SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/14/24 1:28:33 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/13/24 6:42:31 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/6/24 6:59:38 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Schopfer Brian covered exercise/tax liability with 14,801 shares, decreasing direct ownership by 2% to 883,427 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:26:18 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Executive Officer Logan Thomas D covered exercise/tax liability with 54,143 shares, decreasing direct ownership by 1% to 3,943,501 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:24:25 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Human Resources Officer Ulrich Alison covered exercise/tax liability with 2,859 shares, decreasing direct ownership by 8% to 35,230 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:22:48 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MIR
    SEC Filings

    See more

    $MIR
    Financials

    Live finance-specific insights

    See more
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

      Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

      4/21/25 8:15:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software

      Apex-Guard™ Software Version 1.2 Introduces Robust Impurity Analysis for Enhanced Radioisotope Quality Mirion Technologies (NYSE:MIR), a global provider of advanced radiation safety solutions, today announced the latest release of its Apex-Guard gamma spectroscopy software. Tailored to meet the stringent regulatory demands of commercial radioisotope producers, Apex-Guard software V1.2 significantly enhances the Mirion solutions suite within the radiopharmaceutical supply chain with a robust impurity analysis for radioisotope producers. This software release reinforces the Mirion commitment to improving quality in cancer care, through focused innovation across its Mirion Technologies and Mi

      4/1/25 4:03:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-Q filed by Mirion Technologies Inc.

      10-Q - Mirion Technologies, Inc. (0001809987) (Filer)

      4/30/25 4:21:46 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Mirion Technologies, Inc. (0001809987) (Filer)

      4/29/25 4:21:26 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • SEC Form DEFA14A filed by Mirion Technologies Inc.

      DEFA14A - Mirion Technologies, Inc. (0001809987) (Filer)

      4/1/25 4:44:03 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

      Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

      4/21/25 8:15:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Record Fourth Quarter and Record Full Year 2024 Financial Results; Reaffirms Full Year 2025 Guidance

       Revenues for the fourth quarter increased 10.4% to $254.3 million, compared to $230.4 million in the same period in 2023. GAAP net income was $15.9 million in the fourth quarter, compared to a GAAP net loss of $14.5 million in the same period last year; a 210% improvement. Adjusted EBITDA was $69.6 million, a 14.1% increase from $61.0 million in the same period last year. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net loss per share of $0.08 in the fourth quarter of 2023. Adjusted earnings per share for the quarter was $0.17, compared to $0.15 in the same period last year. The company reaffirmed its full year 2025 guidance provided at the Dece

      2/11/25 4:05:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Leadership Updates

    Live Leadership Updates

    See more
    • Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023

      SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail

      9/29/23 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Janus International Appoints David Vanevenhoven as Chief Accounting Officer

      Brings over 15 years of accounting and M&A auditing experience to further enhance Janus's financial reporting and integration capabilities Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of David Vanevenhoven as Chief Accounting Officer, on February 20, 2023. He will report directly to Janus's CFO, Anselm Wong. Mr. Vanevenhoven brings over 15 years of experience in financial accounting and auditing to oversee Janus's accounting function, financial reporting, and internal control

      2/21/23 7:00:00 AM ET
      $JBI
      $MIR
      Building Products
      Industrials
      Industrial Machinery/Components
    • Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

      Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion's CEO, Tom Logan, who had been acting as President of the business segment. Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing le

      10/3/22 8:00:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Robert W. Baird initiated coverage on Mirion Technologies with a new price target

      Robert W. Baird initiated coverage of Mirion Technologies with a rating of Outperform and set a new price target of $22.00

      12/19/24 7:44:58 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • B. Riley Securities initiated coverage on Mirion Technologies with a new price target

      B. Riley Securities initiated coverage of Mirion Technologies with a rating of Buy and set a new price target of $14.00

      9/26/24 7:38:28 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Citigroup resumed coverage on Mirion Technologies with a new price target

      Citigroup resumed coverage of Mirion Technologies with a rating of Buy and set a new price target of $11.00

      5/26/23 7:18:55 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials